Houston, TX – 7/14/2017. DermaClip® US, LLC has been selected to exhibit its non-invasive skin closure device at the 2017 Military Health System Research Symposium (MHSRS). MHSRS 2017 will be held in Kissimmee, Florida on August 27th-30th, 2017 at the Gaylord Palms Resort & Convention Center.
This will mark the second time DermaClip® US, LLC has been invited to exhibit, with the team also making a presentation during the 2016 conference on the use of the innovative, non-invasive DermaClip® skin closure device in the military environment to assist in maintaining readiness and to facilitate the efficient skin closure of injured and wounded warfighters. Dr. Jeffrey Freed, MD, FACS, FACG, and Associate Clinical Professor in the Department of Surgery of Icahn Medical School at Mount Sinai in New York City, and a distinguished medical advisor to the Company, made the presentation.
Charles Darling, CEO of DermaClip® US, LLC, stated: “After the success of last year’s conference, we were gratified that the meeting sponsors agreed with the potential contribution of DermaClip® to the health and readiness of the warfighter and invited us to return to the conference to continue our work supporting the United States military and all of our warfighters. The DermaClip® device can deliver significant benefits in the military environment, from the battlefield abroad to bases at home and enhance treatment alternatives for the injured or wounded warfighter. We look forward to continuing our work towards making DermaClip® available to every member of the military.”
DermaClip® is a revolutionary, new non-invasive skin closure device made of hypoallergenic adhesive coupled with a polypropylene bridge that allows for the quick and easy closure of surface wounds and the final stage of surgical incisions. With no puncturing or crushing of the skin, the patented single-use, needle-less device is designed to evert the skin on every closure to promote healthy healing while being quick and easy to use.
The DermaClip® team believes that high quality skin closure should be available to everyone, regardless of access to high-end services. The team aims to eliminate the trade-offs in skin closure made between time of closure and quality of patient care.
The US operations of DermaClip® are owned and operated by DermaClip® US, L.L.C., a Texas based company.